• 654 Citations
  • 13 h-Index
19962019
If you made any changes in Pure these will be visible here soon.

Personal profile

Education

  • 中山醫學院醫學系學士

Experience

  • 1992年08月 ~迄今 胃腸肝膽科醫師

Fingerprint Dive into the research topics where Pin-Nan Cheng is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 28 Similar Profiles
Chronic Hepatitis C Medicine & Life Sciences
Hepacivirus Medicine & Life Sciences
Chronic Hepatitis B Medicine & Life Sciences
Virus Diseases Medicine & Life Sciences
Ribavirin Medicine & Life Sciences
Genotype Medicine & Life Sciences
Hepatitis B virus Medicine & Life Sciences
Taiwan Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1996 2019

  • 654 Citations
  • 13 h-Index
  • 64 Article
  • 1 Review article

An Open-Label, Randomized, Active-Controlled Trial of 8 Versus 12 Weeks of Elbasvir/Grazoprevir for Treatment-Naive Patients With Chronic Hepatitis C Genotype 1b Infection and Mild Fibrosis (EGALITE Study): Impact of Baseline Viral Loads and NS5A Resistance-Associated Substitutions

Huang, C. F., Hung, C. H., Cheng, P. N., Bair, M. J., Huang, Y. H., Kao, J. H., Hsu, S. J., Lee, P. L., Chen, J. J., Chien, R. N., Peng, C. Y., Lin, C. Y., Hsieh, T. Y., Cheng, C. H., Dai, C. Y., Huang, J. F., Chuang, W. L. & Yu, M. L., 2019 Jul 19, In : The Journal of infectious diseases. 220, 4, p. 557-566 10 p.

Research output: Contribution to journalArticle

Chronic Hepatitis C
Viral Load
Fibrosis
Randomized Controlled Trials
Genotype
1 Citation (Scopus)
Vascular Stiffness
Antiviral Agents
Fibrosis
Chronic Hepatitis C
Blood Pressure
Propensity Score
Hepatocellular Carcinoma
Survival
Liver
Liver Neoplasms
2 Citations (Scopus)

Efficacy and safety of 12 weeks of daclatasvir, asunaprevir plus ribavirin for HCV genotype-1b infection without NS5A resistance-associated substitutions

Yu, M. L., Hung, C. H., Huang, Y. H., Peng, C. Y., Lin, C. Y., Cheng, P-N., Chien, R. N., Hsu, S. J., Liu, C. H., Huang, C. F., Su, C. W., Huang, J. F., Liu, C. J., Kao, J. H., Chuang, W. L., Chen, P. J. & Chen, D. S., 2019 Feb 1, In : Journal of the Formosan Medical Association. 118, 2, p. 556-564 9 p.

Research output: Contribution to journalArticle

Open Access
Ribavirin
Genotype
Safety
Infection
Galectin 3
2 Citations (Scopus)
Open Access
Russia
Hepacivirus
Genotype
Safety
Infection